Mohamedahmed kh, et al. TNF-α Levels and Severe Malaria
2GMJ.2023;12:e2927
www.gmj.ir
anemia through suppression of bone marrow
erythropoiesis and dyserythropoiesis [1, 8].
The overproduction of TNF-α could be asso-
ciated with more rapid resolution of fever and
parasite clearance but predisposes to severe
pathology of disease [9].
Severe malaria is associated with several
genes; including TNF-α gene polymorphisms.
TNF-α is thought to be a critical factor in ma-
laria pathogenesis, the control of parasitemia,
and increased susceptibility to severe malaria
[2, 10].
High TNF-α plasma levels have been asso-
ciated with increased susceptibility to severe
malaria [2, 10]. The variation in the TNF-α
gene phenotypes related to malaria infection
and severe disease [10].
In conclusion, Tumor necrosis factor (TNF-α)
is a common proinammatory cytokine. It
plays a central role in malaria pathogenicity
either in the cure or complication of malaria.
Their high level is associated with the severe
outcome of malaria. [GMJ.2023;12:e2927]
DOI:10.31661/gmj.v12i0.2927
Conict of Interest
The author has declared that no Conict of In-
terest exist.
Keywords
TNF-α; Severe Malaria; Proinammatory Cy-
tokine
References
1. Daa Alla N, Sukkar MY. IFN-γ, TNF-α and
IL-10 responses in children infected with
malaria parasite. Khartoum Med J. 2015;
8(3):1143-1152.
2. Mohamedahmed KA; Abakar AD; Ahmed
MO; Mukhtar MM; Nour BYM. The Role
of TNF-α Levels as Predictive Diagnostic
Biomarker Among Children with Severe Fal-
ciparum Malaria in Endemic Area in Sudan.
IJAHMR. 2019;3(7):1-6.
3. Sinha S, Mishra SK, Sharma S, Patibandla
PK, Mallick PK, Sharma SK, et al. Poly-
morphisms of TNF-enhancer and gene for
FcgammaRIIa correlate with the severity of
falciparum malaria in the ethnically diverse
Indian population. Malar J. 2008;7:13.
4. Thuma PE, van Dijk J, Bucala R, Debebe Z,
Nekhai S, Kuddo T, et al. Distinct clinical
and immunologic proles in severe malarial
anemia and cerebral malaria in Zambia. J
Infect Dis. 2011;203(2):211-9.
5. Deroost K, Pham TT, Opdenakker G, Van
den Steen PE. The immunological balance
between host and parasite in malaria. FEMS
Microbiol Rev. 2016;40(2):208-57.
6. Wammes LJ, Wiria AE, Toenhake CG,
Hamid F, Liu KY, Suryani H et al. Asymp-
tomatic plasmodial infection is associated
with increased tumor necrosis factor receptor
II-expressing regulatory T cells and sup-
pressed type 2 immune responses. J Infect
Dis. 2013;207(10):1590-1599.
7. Cabantous S, Doumbo O, Ranque S, Pou-
diougou B, Traore A, Hou X, et al. Alleles
308A and 238A in the tumor necrosis factor
alpha gene promoter do not increase the risk
of severe malaria in children with Plasmo-
dium falciparum infection in Mali. Infect
Immun. 2006;74(12):7040-7042.
8. Ekvall H. Malaria and anemia. Curr Opin
Hematol. 2003;10(2):108-114.
9. Dodoo D; Omer FM; Todd J; Akanmori BD;
Koram KA; Riley EM. Absolute Levels and
Ratios of Proinammatory and Anti-inam-
matory Cytokine Production In Vitro Predict
Clinical Immunity to Plasmodium falciparum
Malaria. J Infect Dis. 2002;185(7):971-9.
10. Flori L; Delahaye NF; Iraqi FA; Hernan-
dez-Valladares M; Fumoux F; Rihet P.
TNF as a malaria candidate gene: polymor-
phism-screening and family-based associa-
tion analysis of mild malaria attack and par-
asitemia in Burkina Faso. Genes and Immun.
2005;6(6):472-480.